Impact of traditional medicinal plant extracts on antiretroviral drug absorption

Journal of Ethnopharmacology

Volumn 119, Issue 3, 2008, Pages 588-592

  Brown, L ^a   Heyneke, O ^a   Brown, D ^b   van Wyk, J P H ^a   Hamman, J H ^b  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Absorption; Antiretroviral drug; Drug herb interaction; Efflux; Hypoxis hemerocallidea; Sutherlandia frutescens

Indexed keywords

ANTIRETROVIRUS AGENT; CANAVANINE; HYPOXIS HEMEROCALLIDEA EXTRACT; NEVIRAPINE; PLANT EXTRACT; SUTHERLANDIA FRUTESCENS EXTRACT; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; HERB DRUG INTERACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIS; HYPOXIS HEMEROCALLIDEA; INTESTINE EPITHELIUM; MONOLAYER CULTURE; SUTHERLANDIA; SUTHERLANDIA FRUTESCENS; TRADITIONAL MEDICINE;

ANTI-HIV AGENTS; CACO-2 CELLS; CALCIUM CHANNEL BLOCKERS; CANAVANINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; FABACEAE; HUMANS; HYPOXIS; INTESTINAL ABSORPTION; MEDICINE, AFRICAN TRADITIONAL; NEVIRAPINE; PLANT EXTRACTS; PLANTS, MEDICINAL; SOUTH AFRICA; SUSPENSIONS; VERAPAMIL;

HUMAN IMMUNODEFICIENCY VIRUS; HYPOXIS HEMEROCALLIDEA; SUTHERLANDIA FRUTESCENS;

EID: 53449089311     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.06.028     Document Type: Article

References (21)

1. Abdool Karim S.S., Ziqubu-Page T.T., and Arendse R. Bridging the gap: potential for a health care partnership between African traditional healers and biomedical personnel in South Africa. South African Medical Journal 84 (1994) s1-s16
2. Alsenz J.F., Steffen H.F., and Alex R. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharmacological Research 15 (1998) 423-428
3. Balayssac D., Authier N., Cayre A., and Coudore F. Does inhibition of P-glycoprotein lead to drug-drug interactions?. Toxicology Letters 156 (2005) 319-329
4. Budzinski J.W., Foster B.C., Trudeau V.L., Drouin C.E., Bafi-Yeboa N., and Arnason J.T. The interaction of selected phytochemicals, HIV drugs and commercial-source herbal teas and capsules with human cytochrome P450 3A4 and P-glycoprotein. Pharmaceutical Biology 46 (2008) 53-65
5. De Maat M.M., Ekhart G.C., Huitema A.D., Koks C.H.W., Mulder J.W., and Beijnen J.H. Drug interactions between antiretroviral drugs and comedicated agents. Clinical Pharmacokinetics 42 (2003) 223-282
6. Gollapudi S., Reddy M., Gangadharam P., Tsuruo T., and Gupta S. Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic U1 cells chronically infected with HIV type 1. Biochemical and Biophysical Research Communications 1994 (1994) 1181-1187
7. Gupta S. P-glycoprotein expression and regulation: age related changes and potential effects on drug therapy. Clinical Pharmacology 7 (1995) 19-29
8. Hunter J., and Hirst B.H. Intestinal secretions of drugs, the role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanced Drug Delivery Reviews 25 (1997) 129-157
9. Katragadda S., Balasubrhamanyam B., Banmeet S.A., and Mitra A.K. Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opinion in Drug Delivery 2 (2005) 683-705
10. Mills E., Cooper C., Seely D., and Kanfer I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutritional Journal 4 (2005) 1-6
11. Mills E., Foster B.C., Von Heeswijk R., Phillips E., Wilson K., Leonard B., Kosuge K., and Kanfer I. Impact of African herbal medicines on antiretroviral metabolism. AIDS 19 (2005) 95-96
12. Nair V.D.P., Foster B.C., Arnason J.T., Mills E.J., and Kanfer I. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato. Phytomedicine 14 (2007) 498-507
13. Romsicki Y., and Sharom F.J. The ATPase and ATP-binding functions of P-gp: modulation by interaction with defined phospholipids. European Journal of Biochemistry 256 (1998) 170-178
14. Shiraki N., Hamada A., Yasuda K., Fujii J., Arimori K., and Nakano M. Inhibitory effect of human immunodeficiency virus protease inhibitors on the multidrug resistance transporter P-gp. Biological and Pharmaceutical Bulletin 23 (2000) 1528-1531
15. Van Asperen J.F., Van Tellingen O.F., and Beijnen J.H. The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacological Research 37 (1998) 1043-6618
16. Van der Sandt I., Vos C.M., Nabulsi L., Blom-Roosemalen M.C., Voorwinden H.H., De Boer A.G., and Breimer D.D. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier. AIDS 15 (2001) 483-491
17. Van Wyk B.E., Van Outshoorn B., and Gericke N. Medicinal Plants of Southern Africa. 1st ed. (1997), Briza Publications, Pretoria
18. Varma M.V.S., Ashokraj Y., Dey C.S., and Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacological Research 48 (2003) 347-359
19. Vermani K., and Garg S. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology 80 (2002) 46-66
20. WHO, 2001. Traditional medicines show 'encouraging results' in management of HIV/AIDS. [Online]. Available at: http://www.afro.who.int/press/2001/pr20010507.html.
21. Wilkinson D., Gcabashe L., and Lurie M. Traditional healers as tuberculosis treatment supervisors: precedent and potential. International Journal of Tuberculosis and Lung Diseases 3 (1999) 838-842